Articles > Popular publications > Business Wire press releases > April-June 1998 > Friday, June 19

Article: Aphton and SmithKline Beecham Form Strategic Alliance.

Article from:
Business Wire
Article date:
June 19, 1998
Copyright

MIAMI--(BW HealthWire)--June 19, 1998--Aphton Corporation (NASDAQ:APHT) and SmithKline Beecham today announced the signing of a Collaboration and License Agreement for a worldwide strategic alliance for Aphton's Gonadimmune(TM) anti-Gonadotropin Releasing Hormone (anti-GnRH) vaccines.

The agreement covers the diagnosis, treatment and prevention of GnRH-related cancers and other diseases in humans - including - prostate, breast, ovarian and endometrial cancers; and endometriosis, polycystic ovaries, uterine fibroids, contraception, infertility and precocious puberty.

Under the terms of the agreement, SmithKline Beecham will receive exclusive rights worldwide ...

Read all of this article with a FREE trial

Related newspaper, magazine, and journal articles:

Article: SmithKline Beecham Introduces New Laboratory Test ...
PR Newswire;  April 27, 1998 ;     700+ words ... ... 27 /PRNewswire/ -- SmithKline Beecham's clinical laboratory ... Known as SelecTest(TM), offered only by SmithKline Beecham Clinical Laboratories ... distributed to physicians. SmithKline Beecham Clinical Laboratories ...

Article: SmithKline Beecham's Denavir(TM), First ...
PR Newswire;  September 25, 1996 ;     700+ words ... ... 25 /PRNewswire/ -- Denavir(TM) (penciclovir cream), a new treatment ... and Drug Administration (FDA), SmithKline Beecham (NYSE: SBH) announced today ... Kingdom under the brandname Vectavir(TM) for the treatment of cold sores ...

Article: New Parkinson's Disease Drug Requip(TM) Now Available From ...
PR Newswire;  October 14, 1997 ;     700+ words ... ... PRNewswire/ -- SmithKline Beecham (NYSE: SBH) today ... availability of Requip(TM) (ropinirole hydrochloride ... important addition to SmithKline Beecham's line of pharmaceuticals ... Sales and Marketing, SmithKline Beecham Pharmaceuticals ...

Article: FDA APPROVES SMITHKLINE BEECHAM'S ...
PR Newswire;  January 6, 1992 ;     700+ words ...FDA APPROVES SMITHKLINE BEECHAM'S TRIOSTAT(TM) FOR TREATMENT OF MYXEDEMA COMA; RECEIVES ORPHAN DRUG ... treat patients suffering from myxedema coma and precoma, SmithKline Beecham (NYSE: SBH) announced today. TRIOSTAT, which has been ...

Article: CORTECH AND SMITHKLINE BEECHAM COLLABORATE ON ...
PR Newswire;  November 2, 1995 ;     700+ words ... ... Nasdaq: CRTQ) and SmithKline Beecham (NYSE: SBE and SBH ... development of Bradycor(TM), Cortech's lead ... Under the agreement, SmithKline Beecham will pay for future ... extremely pleased to have SmithKline Beecham as a partner," said ...

Article: SmithKline Beecham Introduces New Clear(TM) ...
PR Newswire;  April 18, 2000 ;     700+ words ... ... nicotine patch, SmithKline Beecham Consumer Healthcare now introduces Clear(TM) NicoDerm(R) CQ ... clear patch option. "SmithKline Beecham has been a leader in ... Marketing and Sales, SmithKline Beecham Consumer Healthcare ...

Article: SMITHKLINE BEECHAM'S ALBENZA(TM) CLEARED FOR ...
PR Newswire;  June 12, 1996 ;     700+ words ... ... PRNewswire/ -- SmithKline Beecham (NYSE: SBH) today ... that its Albenza(TM) (albendazole ... and Eskazole(R). SmithKline Beecham -- one of the world ... 751-5419, both of SmithKline Beecham/ /SmithKline Beecham ...

Article: SMITHKLINE BEECHAM'S COREG(TM) CLEARED FOR ...
PR Newswire;  September 14, 1995 ;     626 words ... ... Sept. 14 /PRNewswire/ -- SmithKline Beecham (NYSE: SBE) (SB) today announced ... Administration (FDA) to market Coreg(TM) (carvedilol) for the treatment ... will be made later this year. SmithKline Beecham -- one of the world's leading ...

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!

Find articles, research, and archives